EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Oral Oncology

ISSN 1368-8375 · Elsevier BV

Latest articles

  1. Clinical characteristics and oncologic outcomes of young adults with squamous cell carcinoma of the tongue: A multicenter retrospective study

    L. Gazzini, C. Liberale, G. Guerra, G. Querzoli, M. Ferrari, A. Ruaro, S. Pangallo, C. Montenegro, C. Molendi, G. Belponer, R. Accorona, N. Mevio, F. Pilolli, M. Della Monaca, G. Scivoletto, A. Ferri, F. Cassanelli, G. Petruzzi, M. Fior, F. Mazzola, G. Mannelli, J. Pender Villalvilla, B. Pulli, M. Fermi, E. Serafini, G. Maruccio, D.B. Gissi, A. Marzi Manfroni, A. Brunet, A. Marí, R. Morello, L. Pianta, C. Del Giovane, A. Tarsitano, S. Ferrari, G. Spinelli, V. Valentini, R. Pellini, P. Nicolai, D. Marchioni

    Published: 2026-12DOI: 10.1016/j.oraloncology.2026.108195

  2. A prospective comparative evaluation of dysphagia in surgically resected oral cavity cancers treated by dysphagia optimized volumetric modulated arc therapy (DO-VMAT) versus standard volumetric modulated arc therapy (S-VMAT): DECODE trial

    Pritam Mondal, Sambit Swarup Nanda, Ashutosh Mukherji, Ajay Kumar Choubey, Dhanush, Shubham Dokania, Ninad Harish Patil, Ajay S Krishnan, Narender Kumar, Sanjay Barman, Aseem Mishra, Sunayna Sarkar, Ipsita Dhal, Zachariah Chowdhury, Akhil Kapoor

    Published: 2026-12DOI: 10.1016/j.oraloncology.2026.108222

Volumes

2026 · 3452025 · 5952024 · 4082023 · 2632022 · 5242021 · 7262020 · 4592019 · 3312018 · 3192017 · 3012016 · 2332015 · 2952014 · 2232013 · 6302012 · 2442011 · 7132010 · 2022009 · 2632008 · 1902007 · 1702006 · 1552005 · 1612004 · 1762003 · 1352002 · 1372001 · 1082000 · 941999 · 1031998 · 1181997 · 84

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.